IBRX•benzinga•May 5, 2025 at 10:36 AM

ImmunityBio Requests Receives Refusal to File Letter From FDA For sBLA For ANKTIVA Plus Bacillus Calmette-Guerin; Co. Requests FDA Meeting To Address Change In Agency's Guidance On Jan. 25

No summary available.

Read the full article from the original source for complete details and context.

Article published on May 5, 2025 by benzinga